Immunocore Holdings plc (IMCR) insider trading

Every open-market stock purchase and sale by Immunocore Holdings plc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $5.6M over the last 12 months (7 sales). No open-market buys.
  • Last insider buy: Baker Bros. Advisors LP (Insider), $19.2M, 19 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $5.6M (7 sales). Last close $28.29 on Jun 4, 2026.

Recent IMCR insider trades

DateInsiderTradeValue
May 27, 2026Roy Steven Herbst (Insider)Bought (not open market)—
May 27, 2026Peter John Ratcliffe (Insider)Bought (not open market)—
May 27, 2026William Pao (Insider)Bought (not open market)—
May 27, 2026John Irving Bell (Insider)Bought (not open market)—
May 27, 2026Kristine Peterson (Insider)Bought (not open market)—
May 27, 2026Siddharth Kaul (Insider)Bought (not open market)—
Feb 18, 2026Bahija Jallal (CEO)Sold$371K
Feb 18, 2026David M Berman (Insider)Sold$193K
Feb 18, 2026Tina Amber St Leger (C-suite exec)Sold$32.4K
Feb 18, 2026John Goll (C-suite exec)Sold$22.6K
Feb 17, 2026Travis Alan Coy (CFO)Bought (not open market)—
Feb 17, 2026John Goll (C-suite exec)Bought (not open market)—
Feb 17, 2026John Goll (C-suite exec)Bought (not open market)—
Feb 17, 2026John Goll (C-suite exec)Bought (not open market)—
Feb 17, 2026David M Berman (Insider)Bought (not open market)—
Feb 17, 2026Travis Alan Coy (CFO)Bought (not open market)—
Feb 17, 2026Bahija Jallal (CEO)Bought (not open market)—
Feb 17, 2026Bahija Jallal (CEO)Bought (not open market)—
Feb 17, 2026Bahija Jallal (CEO)Bought (not open market)—
Feb 17, 2026Tina Amber St Leger (C-suite exec)Bought (not open market)—
Dec 5, 2025David M Berman (Insider)Sold$23K
Dec 5, 2025David M Berman (Insider)Bought (not open market)—
Dec 4, 2025David M Berman (Insider)Sold$1.3M
Dec 4, 2025David M Berman (Insider)Bought (not open market)—
Nov 28, 2025David M Berman (Insider)Sold$221K

Who's trading IMCR

Get free alerts when an insider at Immunocore Holdings plc files a new trade →